Fish and seafood are also staples in the ultra-healthy Mediterranean diet, which many people follow while on GLP-1
nausea and vomiting diarrhea constipation stomach pain headache fatigue dizziness excessive gas indigestion and burping abnormal skin sensations Many common Wegovy side effects improve over time as your body adjusts to treatment
Retatrutide and Heart Issues: Cardiovascular Effects, Risks, and Safety Retatrutide and heart issues are a growing focus of clinical interest as this investigational triple agonist advances through trials for obesity and type 2 diabetes
News provided by Novo Nordisk May 07, 2026, 07:00 ET Eligible Medicare patients living with obesity will have access to Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major CV events such as death, heart attack, or stroke in adults living with obesity with known heart disease, a claim only Wegovy can make Novo Nordisk's participation in the Medicare GLP-1 Bridge expands patient access to authentic, FDA-approved Wegovy PLAINSBORO, N.J., May 7, 2026 /PRNewswire/ -- The Medicare GLP-1 Bridge will provide eligible Medicare beneficiaries living with obesity access to Wegovy (semaglutide) injection and tablets for a $50 monthly copay , beginning July 1, 2026, per yesterday's announcement from the Centers for Medicare & Medicaid Services (CMS)
"A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Are Overweight (TRIUMPH-1)." NCT05929066
No matter where you go, you can always balm your dry lips to hydrated and protected ones
